{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:58:22Z","timestamp":1791907102379,"version":"4.3.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>Nuclear protein of the testis carcinoma is an exceedingly rare and poorly differentiated carcinoma characterized by BDR4::NUTM1 gene translocation. Typically, the tumor affects young adults, and no standardized recommendations for therapeutic management have been available since 2022; the clinical course remains mostly dismal. We report the successful multimodal treatment of a 13-year-old boy affected by a primary chest NUT-carcinoma with a novel NUTM1 rearrangement that remains in complete continuous remission at 30 months from diagnosis.<\/jats:p>","DOI":"10.1097\/mph.0000000000002884","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T09:03:12Z","timestamp":1716368592000},"page":"e322-e326","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Novel NUTM1-NSMCE2 Fusion Gene in a Pediatric Chest NUT Carcinoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Francesco","family":"De Leonardis","sequence":"first","affiliation":[{"name":"Division of Paediatric Haematology-Oncology, University Hospital of Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Greco Miani","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haematology-Oncology, University Hospital of Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vallese","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation and Emergency, Thoracic Surgery Unit, University Hospital of Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Barresi","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation and Emergency, Thoracic Surgery Unit, University Hospital of Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Marulli","sequence":"additional","affiliation":[{"name":"Department of Emergencies and Organ Transplantation, Pediatric Surgery, University of Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Novielli","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haematology-Oncology, University Hospital of Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Dall\u2019Igna","sequence":"additional","affiliation":[{"name":"Department of Emergency and Organ Transplantation, Plastic and Reconstructive Surgery and Burns Unit, University of Bari \u201cAldo Moro,\u201d Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maruccia","sequence":"additional","affiliation":[{"name":"Department of Laboratories, Pathology Unit, Bambino Gesu Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Santoro","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haematology-Oncology, University Hospital of Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"R1-20250804","first-page":"3327","article-title":"Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma","volume":"51","author":"Kubonishi","year":"1991","journal-title":"Cancer Res"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"e30821","DOI":"10.1002\/pbc.30821","article-title":"NUT carcinoma in pediatric patients: characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare PediatricTumors (STEP)","volume":"71","author":"Flaadt","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1186\/s12885-021-08432-0","article-title":"Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children\u2019s Hospital","volume":"21","author":"Carter","year":"2021","journal-title":"BMC Cancer"},{"key":"R4-20250804","first-page":"1097","article-title":"NUT carcinoma in children and adolescents: the expert European standard clinical practice harmonized recommendations","volume":"10","author":"Lemelle","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"26693","DOI":"10.1002\/pbc.26693","article-title":"NUT carcinoma in children and adults: A multicenter retrospective study.","volume":"64","author":"Lemelle","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0000000000001021","article-title":"NUTM1 gene fusions characterize a subset of undifferentiated soft tissue and visceral tumors","volume":"42","author":"Dickson","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"pkz094","DOI":"10.1093\/jncics\/pkz094","article-title":"An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients","volume":"4","author":"Chau","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00405-018-4882-y","article-title":"Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases","volume":"275","author":"Giridhar","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1101\/mcs.a003194","article-title":"A recurrent novel MGA\u2013NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma","volume":"4","author":"Diolaiti","year":"2018","journal-title":"Mol Case Stud"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/PAS.0b013e3181abe120","article-title":"NUT midline carcinoma of the parotid gland with mesenchymal differentiation","volume":"33","author":"den Bakker","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/cncy.21761","article-title":"Cytopathologic features of NUT midline carcinoma: a series of 26 specimens from 13 patients","volume":"124","author":"Bishop","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/PAS.0b013e318258f03b","article-title":"Pathologic characteristics of NUT midline carcinoma arising in the mediastinum","volume":"36","author":"Evans","year":"2012","journal-title":"Am J SurgPathol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"690115","DOI":"10.3389\/fonc.2021.690115","article-title":"Immunotherapy and targeting the tumor microenvironment: current place and new insights in primary pulmonary NUT carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","article-title":"Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody","volume":"33","author":"Haack","year":"2009","journal-title":"Am J SurgPathol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/cncr.30242","article-title":"Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck","volume":"122","author":"Chau","year":"2016","journal-title":"Cancer"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","article-title":"Clinicopathologic features and long-term outcomes of NUT midline carcinoma","volume":"18","author":"Bauer","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MPH.0000000000002568","article-title":"NUT carcinoma in children and adolescents: the expert european standard clinical practice harmonized Recommendations","volume":"45","author":"Lemelle","year":"2023","journal-title":"J Pediatr Hematol Oncol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"e30821","DOI":"10.1002\/pbc.30821","article-title":"NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP)","volume":"71","author":"Flaadt","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/pin.12727","article-title":"NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment","volume":"68","author":"French","year":"2018","journal-title":"Pathol Int"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"1018439","DOI":"10.1155\/2019\/1018439","article-title":"An overview of molecular mechanism, clinicopathological factors, and treatment in NUT carcinoma","volume":"2019","author":"Huang","year":"2019","journal-title":"Biomed Res Int"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","article-title":"Clinicopathologic features and long-term outcomes of NUT midline carcinoma","volume":"18","author":"Bauer","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1186\/s12885-021-08432-0","article-title":"Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children\u2019s Hospital","volume":"21","author":"Carter","year":"2021","journal-title":"BMC Cancer"},{"key":"R24-20250804","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26693","article-title":"NUT carcinoma in children and adults: A multicenter retrospective study","volume":"64","author":"Lemelle","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"e1232","DOI":"10.1634\/theoncologist.2019-0358","article-title":"NUT carcinoma is a rare and challenging tumor: single center experience of five children","volume":"24","author":"Prasad","year":"2019","journal-title":"Oncologist"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/08880018.2017.1363839","article-title":"Pediatric NUT-midline carcinoma: therapeutic success employing a sarcoma based multimodal approach","volume":"34","author":"Storck","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13023-020-01449-x","article-title":"Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma","volume":"15","author":"Xie","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00405-018-4882-y","article-title":"Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases","volume":"275","author":"Giridhar","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"pkz094","DOI":"10.1093\/jncics\/pkz094","article-title":"An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients","volume":"4","author":"Chau","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"690115","DOI":"10.3389\/fonc.2021.690115","article-title":"Immunotherapy and targeting the tumor microenvironment: current place and new insights in primary pulmonary NUT carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/acr-19-168","article-title":"The primary pulmonary NUT carcinomas and some uncommon somatic mutations identified by next-generation sequencing: a case report","volume":"4","author":"Liu","year":"2020","journal-title":"AME Case Rep"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1016\/j.cllc.2020.10.016","article-title":"prolonged disease control on nivolumab for primary pulmonary NUT carcinoma","volume":"22","author":"Davis","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"e04616","DOI":"10.1002\/ccr3.4616","article-title":"A case of metastatic NUT carcinoma with prolonged response on gemcitabine and nab-paclitaxel","volume":"9","author":"Patel","year":"2021","journal-title":"Clin Case Rep"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12105-020-01141-3","article-title":"salivary gland NUT carcinoma with prolonged survival in children: case illustration and systematic review of literature","volume":"15","author":"Wang","year":"2021","journal-title":"Head Neck Pathol"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2169\/internalmedicine.7741-21","article-title":"Complete response induced by concurrent chemoradiotherapy in a patient with NUT carcinoma","volume":"61","author":"Muramatsu","year":"2022","journal-title":"Intern Med"},{"key":"R36-20250804","first-page":"1","article-title":"durable complete remission of PD-L1 positive NUT carcinoma treated with concurrent chemotherapy and radiation","author":"Pan","year":"2020","journal-title":"Perm J"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"995744","DOI":"10.3389\/fonc.2022.995744","article-title":"Case report: immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma","volume":"12","author":"Kloker","year":"2022","journal-title":"Front Oncol"},{"key":"R38-20250804","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/pbc.20755","article-title":"Successful treatment of a child with t(15;19)-positive tumor","volume":"49","author":"Mertens","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"e26946","DOI":"10.1002\/pbc.26946","article-title":"Long-term survival after relapsed NUT carcinoma of the larynx","volume":"65","author":"Vorstenbosch","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejca.2021.01.018","article-title":"Bromodomain and extra-terminal inhibitors\u2014a consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE","volume":"146","author":"Pearson","year":"2021","journal-title":"Eur J Cancer"},{"key":"R41-20250804","doi-asserted-by":"crossref","first-page":"1018439","DOI":"10.1155\/2019\/1018439","article-title":"An overview of molecular mechanism, clinicopathological factors, and treatment in NUT carcinoma","volume":"2019","author":"Huang","year":"2019","journal-title":"BioMed Res Int"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"20201289","DOI":"10.1259\/bjr.20201289","article-title":"Volumetric modulated arc therapy (VMAT): a review of clinical outcomes\u2014what is the clinical evidence for the most effective implementation?","volume":"95","author":"Hunte","year":"2022","journal-title":"Br J Radiol"},{"key":"R43-20250804","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/gcc.22838","article-title":"Emerging entities in NUTM1-rearranged neoplasms","volume":"59","author":"McEvoy","year":"2020","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:06:38Z","timestamp":1754337998000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002884","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"2023-10-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}